HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Devos Selected Research

Glucosylceramides (Glucocerebrosides)

10/2020Glycosphingolipids and neuroinflammation in Parkinson's disease.
1/2020Trends in Glucocerebrosides Research: A Systematic Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Devos Research Topics

Disease

55Parkinson Disease (Parkinson's Disease)
04/2024 - 09/2006
15Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2024 - 02/2012
11Disease Progression
04/2024 - 07/2014
11Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 10/2016
7Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2022 - 12/2011
6Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2019
5Neoplasms (Cancer)
01/2023 - 07/2014
5Neuroinflammatory Diseases
11/2021 - 10/2017
5Inflammation (Inflammations)
01/2019 - 10/2011
4Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023 - 01/2019
4Dyskinesias (Dyskinesia)
01/2020 - 08/2007
4Dementia (Dementias)
06/2014 - 09/2006
3Atrophy
01/2023 - 06/2014
3Movement Disorders (Movement Disorder)
01/2022 - 10/2013
3Siderosis
01/2020 - 12/2013
3Cognitive Dysfunction
01/2020 - 06/2014
2Infections
01/2023 - 08/2007
2Parkinsonian Disorders (Parkinsonism)
12/2022 - 01/2014
2Body Weight (Weight, Body)
12/2022 - 01/2014
2REM Sleep Behavior Disorder
01/2022 - 11/2021
2Iron Overload
01/2022 - 01/2016
2Cerebellar Ataxia (Dysmetria)
01/2022 - 01/2022
2Hypokinesia (Bradykinesia)
08/2014 - 07/2012
2Friedreich Ataxia (Friedreich's Ataxia)
12/2013 - 03/2012
2Ataxia (Dyssynergia)
10/2013 - 03/2012
2Shock
09/2012 - 07/2011
1Vomiting
04/2024
1Nausea
04/2024
1Neck Pain (Cervicalgia)
11/2023
1Deglutition Disorders (Dysphagia)
11/2023
1Tremor (Tremors)
11/2023
1Spinal Cord Injuries (Spinal Cord Injury)
01/2023
1Neutropenia
12/2022
1Agranulocytosis (Granulocytopenia)
12/2022
1Dizziness (Lightheadedness)
01/2022
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022
1Neuroferritinopathy
01/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Nervous System Heredodegenerative Disorders
01/2022
1Mania (Manias)
01/2022
1Retinal Dystrophies
01/2022
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2021

Drug/Important Bio-Agent (IBA)

24IronIBA
10/2023 - 12/2013
11Biomarkers (Surrogate Marker)IBA
04/2024 - 08/2013
8Levodopa (L Dopa)FDA LinkGeneric
12/2022 - 08/2007
7Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2019
6Chelating AgentsIBA
12/2022 - 12/2013
6Dopamine (Intropin)FDA LinkGeneric
01/2022 - 07/2012
5DeferiproneIBA
12/2022 - 12/2013
3ApomorphineFDA Link
09/2023 - 06/2016
3Methylphenidate (Ritalin)FDA LinkGeneric
05/2015 - 07/2012
2Nerve Growth Factors (Neurotrophins)IBA
01/2023 - 10/2017
2Transferrin (beta 2 Transferrin)IBA
01/2022 - 01/2019
2Dihydroxyphenylalanine (Dopa)IBA
01/2022 - 06/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021 - 10/2016
2Interleukin-4 (Interleukin 4)IBA
06/2021 - 01/2021
2Interleukin-10 (Interleukin 10)IBA
06/2021 - 01/2021
2GlycosphingolipidsIBA
10/2020 - 01/2020
2Glucosylceramides (Glucocerebrosides)IBA
10/2020 - 01/2020
2Oxygen (Dioxygen)IBA
01/2020 - 02/2012
2LipidsIBA
01/2019 - 01/2018
2Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
01/2019 - 03/2012
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2017 - 01/2016
2Rivastigmine (Exelon)FDA LinkGeneric
06/2014 - 09/2006
2Cholinesterase Inhibitors (Anticholinesterases)IBA
10/2013 - 09/2006
2Cholinergic Agents (Cholinergics)IBA
10/2013 - 09/2006
2Retinaldehyde (Retinal)IBA
12/2011 - 03/2011
1Indicators and Reagents (Reagents)IBA
04/2024
1lixisenatideIBA
04/2024
1Glucagon-Like Peptide-1 ReceptorIBA
04/2024
1Type A Botulinum Toxins (Botox)FDA Link
11/2023
1Botulinum Toxins (Botulinum Toxin)IBA
11/2023
1AntioxidantsIBA
01/2023
1Immunoglobulins (Immunoglobulin)IBA
01/2023
1CytokinesIBA
01/2023
1Lipid PeroxidesIBA
01/2023
1Clozapine (Clozaril)FDA LinkGeneric
01/2022
1Biocompatible Materials (Biomaterials)IBA
01/2022
1Ataxin-7IBA
01/2022
1RiluzoleFDA LinkGeneric
01/2022
1Dopamine Agonists (Dopamine Agonist)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
06/2021
1Interleukin-1beta (Interleukin 1 beta)IBA
06/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2021
1Caspase 1 (ICE Protease)IBA
06/2021
1Toll-Like Receptor 4IBA
06/2021
1Heme Oxygenase-1IBA
06/2021
1Interleukin-13IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1alpha-SynucleinIBA
01/2021
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
01/2021
1GangliosidesIBA
10/2020
1SphingolipidsIBA
01/2020

Therapy/Procedure

10Therapeutics
04/2024 - 05/2009
9Deep Brain Stimulation
02/2024 - 01/2011
4Biological Therapy
01/2022 - 11/2017
3Transcranial Magnetic Stimulation
10/2021 - 07/2011
2Intranasal Administration
01/2023 - 10/2017
2Activities of Daily Living (ADL)
11/2021 - 08/2007
1Injections
11/2023